
Attorneys general of four states—Massachusetts, California, New Jersey and New York—asked the U.S. Food and Drug Administration (FDA) on Thursday, June 5, to lift long-standing restrictions on the medication mifepristone. The drug is used in approximately two-thirds of abortions in the United States.
The petition came just three days after the FDA commissioner Marty Makary announced his decision to “review” the agency’s regulation of mifepristone after previously stating he had no plans to restrict the medication.
“Given mifepristone’s 25-year safety record, there is simply no scientific or medical reason to subject it to such extraordinary restrictions,” said New York Attorney General Letitia James. “New Yorkers, and all Americans, deserve access to this safe, effective and essential medication without burdensome, unjustified restrictions. The FDA must follow the science and lift these unnecessary barriers that put patients at risk and push providers out of care.”